TRAIL/Apo-2L: Mechanisms and Clinical Applications in Cancer
TNF-related apoptosis-inducing ligand (TRAIL/APO2L) is a member of the TNF family that promotes apoptosis by binding to the transmembrane receptors TRAIL-R1 /DR4 and TRAIL-R2/DR5. Its cytotoxic activity is relatively selective to the human tumor cell lines without much effect on the normal cells. He...
Main Author: | Rakesh K. Srivastava |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2001-01-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558601800099 |
Similar Items
-
Overcoming TRAIL Resistance for Glioblastoma Treatment
by: Longfei Deng, et al.
Published: (2021-04-01) -
Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling
by: You-Take Oh, et al.
Published: (2021-03-01) -
TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors
by: Xi Yang, et al.
Published: (2017-01-01) -
The survival of Amblyomma sculptum ticks upon blood-feeding depends on the expression of an inhibitor of apoptosis protein
by: Marcelly Nassar, et al.
Published: (2023-03-01) -
Accelerated Degradation of Caspase-8 Protein Correlates with TRAIL Resistance in a DLD1 Human Colon Cancer Cell Line
by: Lidong Zhang, et al.
Published: (2005-06-01)